Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMineral & Financial Investments Regulatory News (MAFL)

Share Price Information for Mineral & Financial Investments (MAFL)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £18.65m
MAFL Live PriceLast checked at - London Stock Exchange

Intraday Mineral & Financial Investments Share Chart

Correction: Quarterly Net Asset Value

17 Apr 2019 12:30

RNS Number : 5171W
Mineral & Financial Invest. Limited
17 April 2019
 

MINERAL AND FINANCIAL INVESTMENTS LIMITED

Correction: Quarterly Net Asset Value

 

 

NET ASSET VALUE

 

It has come to the Company's attention that the calculations for the quarterly Net Asset Value per share quoted in previous announcements, and more particularly the announcements dated 27 March 2019, 1 November 2018 and 31 July 2018, were not expressed clearly.

 

Accordingly, the Company sets out its calculations for both the basic and fully diluted Net Asset Value per share, below.

 

These calculations will also be incorporated in the Company's quarterly Net Asset Value update going forward.

 

2016

 

 

 

 

 

Mar. 31 2016

Jun. 30 2016

Sep. 30 2016

Dec. 31 2016*

NET ASSET VALUE (NAV)

£912,938

£1,048,857

£1,558,156

£1,494,360

Cost of Exercising Options

£39,450

£39,450

£39,450

£39,450

Total NAV

£952,388

£1,088,307

£1,597,606

£1,533,810

 

 

 

 

 

Number of shares in issue

14,034,562

14,034,562

24,034,562

24,034,562

Unexercised options

500,000

500,000

500,000

500,000

 

14,534,562

14,534,562

24,534,562

24,534,562

Basic: NET ASSET VALUE PER SHARE (NAVPS)

6.50p

7.47p

6.48p

6.22p

Fully diluted NAVPS

6.55p

7.49p

6.51p

6.25p

 

 

 

 

 

 

 

 

 

 

2017

 

 

 

 

 

Mar. 31 2017

Jun. 30 2017

Sep. 30 2017

Dec. 31 2017

NET ASSET VALUE (NAV)

£2,509,774

£2,443,373

£2,387,321

£2,602,816

Cost of Exercising Options

£84,450

£84,450

£84,450

£61,604

Total NAV

£2,594,224

£2,527,823

£2,471,771

£2,664,420

 

 

 

 

 

Number of shares in issue

34,742,895

34,742,895

34,742,895

35,037,895

Unexercised options

1,100,000

1,100,000

1,100,000

805,000

 

35,842,895

35,842,895

35,842,895

35,842,895

Basic: NET ASSET VALUE PER SHARE (NAVPS)

7.22p

7.03p

6.87p

7.43p

Fully diluted NAVPS

7.24p

7.05p

6.90p

7.43p

 

 

 

 

 

 

2018

 

 

 

 

 

Mar. 31 2018

Jun. 30 2018*

Sep. 30 2018

Dec. 31 2018

NET ASSET VALUE (NAV)

£2,536,875

£2,623,134

£2,358,580

£4,392,940

Cost of Exercising Options

£61,604

£61,604

£61,604

£61,604

Total NAV

£2,598,479

£2,684,738

£2,420,184

£4,454,544

 

 

 

 

 

Number of shares in issue

35,037,895

35,037,895

35,037,895

35,037,895

Unexercised options

805,000

805,000

805,000

805,000

 

35,842,895

35,842,895

35,842,895

35,842,895

Basic: NET ASSET VALUE PER SHARE (NAVPS)

7.24p

7.49p

6.73p

12.54p

Fully diluted NAVPS

7.25p

7.49p

6.75p

12.43p

 

*indicates audited numbers.

 

FOR MORE INFORMATION:

Jacques Vaillancourt, Mineral & Financial Investments Ltd.

+44 780 226 8247

Katy Mitchell and Jessica Cave, WH Ireland Limited

+44 161 832 2174

Jon Belliss, Novum Securities Limited

+44 207 382 8300

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVBBGDSSDBBGCR
Date   Source Headline
28th May 20269:22 amRNSHolding(s) in Company
18th Mar 20267:00 amRNSInterim Results
30th Jan 20263:09 pmRNSConversion Of Vested RSUs into Ordinary Shares
28th Jan 20267:00 amRNSHolding(s) in Company
27th Jan 202611:38 amRNSHolding(s) in Company
20th Jan 20261:06 pmRNSResult of AGM
20th Jan 20267:00 amRNS1st Quarter Results
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
22nd Dec 20257:00 amRNSAudited Results for Year Ended 30 June 2025
7th Oct 20252:35 pmRNSDirector/PDMR Shareholding
20th Aug 20258:45 amRNSGrant of RSU's and Exercise of Options
14th Jul 202511:22 amRNSUpdate on Redcorp's Lagoa Salgada EIA Application
12th Jun 20256:18 pmRNSHolding(s) in Company
6th Jun 20259:39 amRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSUnaudited Quarterly Results
22nd May 20255:28 pmRNSDirector/PDMR Shareholding
7th May 20255:21 pmRNSDirector/PDMR Shareholding
7th May 20254:26 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSIssue of Equity
20th Mar 20255:13 pmRNSInvestment in Physical Silver
20th Mar 20257:00 amRNSInterim Results for Six Months Ended 31 Dec 24
7th Mar 202511:45 amRNSHolding(s) in Company
4th Feb 20257:00 amRNSInvestment Update: Ascendant
22nd Jan 202512:20 pmRNSDirector/PDMR Shareholding
16th Jan 20251:24 pmRNSReplacement: Unaudited Quarterly Net Asset Value
16th Jan 20257:00 amRNSUnaudited Quarterly Net Asset Value
18th Dec 20242:52 pmRNSResult of AGM
11th Dec 202411:05 amRNSInvestment Update: Ascendant / Redcorp
25th Nov 20242:37 pmRNSHolding(s) in Company
19th Nov 20245:53 pmRNSAudited Results for Year Ended 30 June 2024
1st Nov 202411:03 amRNSInvestment Update: Ascendant / Redcorp
15th Oct 202411:00 amRNSInvestment Update: Redcorp
30th Sep 202411:00 amRNSInvestment Update: Ascendant / Redcorp
19th Sep 20247:00 amRNSInvestment Update: Ascendant / Redcorp
17th Jul 20247:00 amRNSInvestment Update: Redcorp
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
12th Jul 20247:00 amRNSDirector Update
13th Jun 20247:00 amRNSUnaudited Quarterly Net Asset Value
29th Apr 20247:00 amRNSDirector Dealing
10th Apr 20244:22 pmRNSHolding(s) in Company
10th Apr 202411:00 amRNSInvestment Update: Ascendant / Redcorp
27th Mar 20247:00 amRNSInterim Results for Six Months Ended 31 Dec 23
29th Feb 20241:01 pmRNSCorrection - Investment Update: Ascendant /Redcorp
29th Feb 20247:00 amRNSInvestment Update: Ascendant / Redcorp
5th Feb 20247:00 amRNSUnaudited Quarterly Net Asset Value
31st Jan 20246:04 pmRNSResult of AGM
8th Jan 20247:00 amRNSDirector Dealing
3rd Jan 202411:00 amRNSInvestment Update: Ascendant / Redcorp
28th Dec 20232:29 pmRNSNotice of AGM and Posting of Annual Report
20th Dec 20235:25 pmRNSAudited Results for Year Ended 30 June 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.